StockData

HealthLynked Corp (HLYK) shareholders

HLYKOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$2.09+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.14MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.0%
0M of 3M shares
Institutional holders
1
0 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of HLYKValueChange% of portfolio
Ancora Advisors, LLC740.00%$222–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202610M0.0%0 / 00 / 00M0M
Q1 202610M0.0%0 / 00 / 00M0M
Q4 202510M0.0%0 / 00 / 00M0M
Q3 202510M0.0%1 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
George O'LearyChief Financial Officer, Director4,117,896139.44%Jul 24, 2026
Michael T. DentChief Executive Officer, Director, 10% owner85,007,1122878.45%Apr 18, 2025
Jeremy DanielChief Financial Officer––Jan 15, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
David Rosal
Chief Financial Officer
Jun 24, 2024Buy+28,333$0.08$2.27K62,000
David Rosal
Chief Financial Officer
Jun 20, 2024Buy+33,667$0.08$2.69K33,667
Heather Monahan
Director
Sep 27, 2023Award+408,163––1,181,697
Paul Hobaica
Director
Sep 27, 2023Award+408,163––569,107
Daniel L. Hall
Director
Sep 27, 2023Award+408,163––1,181,697
Robert P. Gasparini
Director
Sep 27, 2023Award+408,163––2,880,191
Michael T. Dent
Chief Executive Officer, Director, 10% owner
Jan 27, 2023Award+50,000––3,010,640
George O'Leary
Chief Financial Officer, Director
Jan 27, 2023Award+50,000––929,115
Heather Monahan
Director
Dec 8, 2022Award+536,193––773,534
Robert P. Gasparini
Director
Dec 8, 2022Award+536,193––2,472,028
Daniel L. Hall
Director
Dec 8, 2022Award+536,193––773,534
George O'Leary
Chief Financial Officer, Director
Oct 20, 2022Award+400,000––879,115
Michael T. Dent
Chief Executive Officer, Director, 10% owner
Dec 21, 2021Award+2,000––2,960,640
George O'Leary
Chief Financial Officer, Director
Dec 21, 2021Award+2,000––479,115
Robert P. Mino
Director
Nov 22, 2021Award+74,766––638,604
Heather Monahan
Director
Nov 22, 2021Award+74,766––237,341
Robert P. Gasparini
Director
Nov 22, 2021Award+74,766––1,935,835
Daniel L. Hall
Director
Nov 22, 2021Award+74,766––237,341
Heather Monahan
Director
Nov 12, 2021Award+68,942––231,517
Daniel L. Hall
Director
Nov 12, 2021Award+68,942––231,517
Robert P. Gasparini
Director
Nov 12, 2021Award+68,942––1,930,011
Robert P. Mino
Director
Nov 12, 2021Award+68,942––632,780
Robert P. Gasparini
Director
Jul 21, 2021Option exercise+312,250$0.10$31.23K1,779,532
Robert P. Gasparini
Director
Apr 30, 2021Award+354,234––1,467,282
Heather Monahan
Director
Apr 30, 2021Award+81,288––81,288
Robert P. Mino
Director
Apr 30, 2021Award+289,694––482,551
Robert P. Mino
Director
Mar 2, 2021Buy+50,000$0.50$25.00K192,857
George O'Leary
Chief Financial Officer, Director
Mar 1, 2021Buy+50,000$0.50$25.00K3,757,328
Michael T. Dent
Chief Executive Officer, Director, 10% owner
Jan 13, 2021Award+5,000––84,955,112
George O'Leary
Chief Financial Officer, Director
Jan 13, 2021Award+5,000––3,535,213
George O'Leary
Chief Financial Officer, Director
Jan 13, 2021Buy+100,000––3,635,213
Daniel L. Hall
Director
Nov 9, 2020Award+162,575––162,575
Michael T. Dent
Chief Executive Officer, Director, 10% owner
Oct 19, 2020Other+10,573,745$0.14$1.48M84,950,112
George O'Leary
Chief Financial Officer, Director
Oct 19, 2020Other+1,130,213$0.14$158.23K3,530,213
Robert P. Gasparini
Director
Oct 19, 2020Other+99,437$0.14$13.92K1,113,048
Michael T. Dent
Chief Executive Officer, Director
Aug 24, 2020Other+24,522,727$0.12$2.94M74,376,367
George O'Leary
Chief Financial Officer, Director
Jul 20, 2020Award+100,000––2,400,000
Robert P. Mino
Director
Jan 3, 2020Award+142,857$0.14$20.00K142,857
George O'Leary
Chief Financial Officer, Director
Jul 1, 2018Award+100,000––2,200,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Sep 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
–
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of HealthLynked's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?